Healthcare -
Biotechnology - NASDAQ - US
$ 9.78
-1.71 %
$ 135 M
Market Cap
-195.6
P/E
CSBR - STOCK-BASED COMPENSATION
Stock-based Compensation CSBR - Champions Oncology, Inc.
1.12 M
LAST VALUE
10.72%
2 YEAR CAGR
11.94%
5 YEAR CAGR
-8.79%
10 YEAR CAGR